A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors

NCT06907628 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-3792 Injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.